Member Info for chasrutledge

Professor John Oxford, Chairman of Open Orphan's Scientific Advisory Board, commented:

"After almost 5 years' of absence from hVIVO, I'm delighted to be more involved again and particularly to be back involved as Chairman of the Scientific Advisory Board. Over the years, I have had extensive experience in dealing with novel and threatening viruses and in 2009 I was the first person, in conjunction with the hVIVO laboratory, to get permission from the government to bring the SARS virus into the country in order to analyse it as part of seeking a solution to the outbreak.

A couple of years ago, the hVIVO Scientific team started a project to potentially develop a Coronavirus challenge study model but after a certain amount of work and effort they suspended this project because they didn't see sufficient market demand for a Coronavirus challenge study model. However, in recent weeks, the hVIVO scientific team led by their Chief Scientist Andrew Catchpole have reopened their Coronavirus challenge study project and work files. Given the unfortunate circumstances of Covid-19 now spreading around the world they and I felt that there was an obligation on us to reactivate the project and to do our best to now swiftly and effectively make a Coronavirus challenge study model available to the market as soon as possible.

I'm looking forward to working with the team in the days and weeks ahead to do our best to make the world's first Coronavirus challenge study model available as soon as possible."

Cathal Friel, Executive Chairman of Open Orphan, commented:

"This is an important milestone in the development and evolution of Open Orphan and particularly the Company's subsidiary hVIVO which is based in London, UK. We are very happy to be able to try and assist in the battle against Covid-19. Our hVIVO scientists and virologists, and especially hVIVO's founder and the now Chairman of our Scientific Advisory Board Prof John Oxford, have a long history and experience of successfully developing challenge studies.

This development also reinforces the strength of hVIVO's reputation as a world leader in providing services to global vaccine and anti-viral production companies and is another example of the growth potential for Open Orphan. A considerable amount of the work around this project has already been carried out and the project takes advantage of the significant knowledge and experience gained from hVIVO's previous challenge virus manufacturing campaigns. We are delighted to be working with Mike Wang of the international law firm King & Wood Mallesons who is working with us to secure funders for this project from his network of Chinese pharmaceutical and life science companies. "

The Company is in early discussions with King & Wood Mallesons, acting on behalf of selected Chinese pharmaceutical and life science clients, to secure funding for the further development of this Coronavirus challenge study. It is intended that the major cost of developing this Coronavirus human challenge model will be primarily funded by new Chinese pharmaceutical partner companies who will get a return on their investment from royalties on the sale of this particular challenge study model.

hVIVO is the world leader in the provision of virology and vaccine challenge study services, is pleased to announce that it has commenced the development of the world's first commercial human coronavirus challenge study model, also known as a Controlled Human Infection Model (CHIM)

https://www.valuethemarkets.com/2020/02/12/video-open-orphans-cathal-friel-details-ambitions-2020-plans-following-5-3m-raise-in-exclusive-presentation-orph/

https://www.irishtimes.com/business/health-pharma/open-orphan-seals-deal-that-could-net-more-than-11-6m-1.4194966

Strong day today. Delighted with my purchase and was willing to buy for a higher price. Feel like a mini millionaire already. yippee. Now lets get digging.

blue day ahead :)

My apologies faze1 if I made a mistake.

I got in for a top up at 0.415. Cleaned up my portfolio and took out the rubbish.

5.07% down to 4.13% little tree shake?

yep I know.

relax a bit lads till i get in. haha 1 hour to go till I can make the call.

looks good on barchart. Got that yesterday after reading someones share chat. Cheers

By the way Cheltengham races (67500 spectators) is not being cancelled and Paddys day (god Knows how many spectators) is going ahead. But congregating at shopping centers or bus stops is not allowed. Also you can not shake hands at church anymore. And creches might close. And the army might be called in to stop civil unrest. But paint your face green, have a few beers and put a bet on a horse yeah? Has the world gone mad??

Fair Value is roughly 7.77. This is just crazy. Time to buy.

Come on BIRG I know you can do it. ;-). Suppot at 3.25

am i the only one here??

check tym shares on google

what news? have you a link?